Patents by Inventor Maximillian Taro William LEE

Maximillian Taro William LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250041435
    Abstract: The present disclosure relates to binding molecules (e.g. antibodies) for the treatment of cancer, and related antibody-drug conjugates.
    Type: Application
    Filed: April 10, 2024
    Publication date: February 6, 2025
    Inventors: Asurayya WORREDE, Frank COMER, Jeong Min HAN, Eric James MOORE, Sujiet PUTHENVEETIL, Vanessa MUNIZ-MEDINA, Dewald van DYK, Sao Fong CHEUNG, Melanie EHUDIN, Darlene MONLISH, Akbar Husain KHAN, Andreas Lothar Severino MADERNA, Maximillian Taro William LEE, Nicole Danielle BARTOLO
  • Patent number: 12178876
    Abstract: The specification relates to conjugates comprising a linker of Formula (ICA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Grant
    Filed: April 9, 2024
    Date of Patent: December 31, 2024
    Assignee: AstraZeneca, AB
    Inventors: Akbar Husain Khan, Andreas Lothar Severino Maderna, Maximillian Taro William Lee, Nicole Danielle Bartolo, William Robert Fraser Goundry
  • Publication number: 20240366768
    Abstract: The specification relates to conjugates comprising a linker of Formula (ICA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: April 9, 2024
    Publication date: November 7, 2024
    Inventors: Akbar Husain KHAN, Andreas Lothar Severino MADERNA, Maximillian Taro William LEE, Nicole Danielle BARTOLO, William Robert Fraser GOUNDRY
  • Publication number: 20240366781
    Abstract: The specification relates to conjugates comprising a linker of Formula (IA): and pharmaceutically acceptable salts thereof. The specification also relates the use of the conjugates for the treatment of diseases such as cancer, and intermediates useful for the synthesis of the conjugates.
    Type: Application
    Filed: April 9, 2024
    Publication date: November 7, 2024
    Inventors: Akbar Husain KHAN, Andreas Lothar Severino MADERNA, Maximillian Taro William LEE, Mattia COCCO, Boliang DENG, Jonathan David BEADLE, Albano GALAN COCA, Alla PRYYMA, Nicole Danielle BARTOLO, Luke MASTERSON, William Robert Fraser GOUNDRY